Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

@article{Korte2002SystemicBA,
  title={Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops},
  author={J M Korte and Timo J Kaila and Matti K. Saari},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={2002},
  volume={240},
  pages={430-435}
}
Background. To investigate the pharmacological basis of systemic side effects of ophthalmic timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared cardiopulmonary effects of intravenous and ophthalmic timolol. Methods. In a randomized crossover study we administered 0.2 mg timolol either intravenously or ocularly to eight healthy volunteers. After drug administration we measured heart rate, arterial blood pressure, forced expiratory volume in 1 s, forced vital… CONTINUE READING
30 Citations
16 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Beta-blocking effects of timolol at low plasma levels

  • T Kaila, R Huupponen, +4 authors L Salminen
  • Clin Pharmacol Ther
  • 1990
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…